Host Cofactors and Pharmacologic Ligands Share an Essential Interface in HIV-1 Capsid That Is Lost upon Disassembly
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The HIV-1 capsid is involved in all infectious steps from reverse transcription to integration site selection, and is the target of multiple host cell and pharmacologic ligands. However, structural studies have been limited to capsid monomers (CA), and the mechanistic basis for how these ligands influence infection is not well understood. Here we show that a multi-subunit interface formed exclusively within CA hexamers mediates binding to linear epitopes within cellular cofactors NUP153 and CPSF6, and is competed for by the antiretroviral compounds PF74 and BI-2. Each ligand is anchored via a shared phenylalanine-glycine (FG) motif to a pocket within the N-terminal domain of one monomer, and all but BI-2 also make essential interactions across the N-terminal domain: C-terminal domain (NTD:CTD) interface to a second monomer. Dissociation of hexamer into CA monomers prevents high affinity interaction with CPSF6 and PF74, and abolishes binding to NUP153. The second interface is conformationally dynamic, but binding of NUP153 or CPSF6 peptides is accommodated by only one conformation. NUP153 and CPSF6 have overlapping binding sites, but each makes unique CA interactions that, when mutated selectively, perturb cofactor dependency. These results reveal that multiple ligands share an overlapping interface in HIV-1 capsid that is lost upon viral disassembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 CPSF6 and NUP153 interact with distinct sets of CA residues within the hexamer interface. A molecular surface representation of the CPSF6 and NUP153 binding site in hexameric capsid is shown in gray. The interface is formed between two neighbouring monomers and is shown in a similar orientation to Figure 3. The CPSF6 (A) and NUP153 (B) peptides in the different complexed structures are shown in yellow and pink respectively. The binding ‘footprint’ of each ligand is shown in red for CPSF6 and yellow for NUP153. The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.e. are within 1.4 Å of the ligand).](https://figures.cochat.ai/paper-figures/327adc62c78b4401a48bf088e2d7894f/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-4.jpg)


![Figure 7 HIV-1 CA hexamer complexes with pharmacologic ligands BI-2 and PF74. Two monomers from hexameric structures complexed with BI-2 (A) and PF74 (B) are shown in a close-up view of the binding site, with one monomer in gray and a second monomer in teal. BI-2 is shown in orange and PF74 in green. Important CA interacting residues are shown as sticks and putative hydrogen bonds indicated by dashed lines. Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond. Other interacting CA residues are indicated with a red-dashed semi-circle. Circled areas indicate interacting CA residues that are shared between both structures. (E) Superposition of the BI-2:hexamer complex (BI-2 in orange) with the previously solved BI-1:CA-NTD complex [28] (BI-1 in blue). The secondary structure of the superposed monomers from each structure is shown in gray, while capsid side-chains from only the hexamer complex are depicted. The adjacent monomer in the hexamer complex is shown in teal. (F) Superposition of the PF74:hexamer complex (PF74 in green) with the previously solved PF74:CA-NTD complex [27] (PF74 in slate). The capsids are colored as in (E).](https://figures.cochat.ai/paper-figures/7cf5249be85940bd90f08d2edaf59d69/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-7.jpg)

![Figure 9 Inhibition of HIV-1 infection by BI-2, PF74 and PF74 derivatives. (A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vector. For each titration, infectivity is normalised to the level in the absence of inhibitor (100%). (B) Correlation between the IC90 values derived from (A) and the Kd values for purified hexameric capsid as calculated by ITC (Figure 8). The values are highly correlative with a Pearson correlation coefficient of 0.9928 and a P-value of 0.0007. (C) Titration of PF74 or BI-2 onto cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vectors, normalized as in (A). (D) Data from (C) but with infectivity plotted against drug concentration divided by affinity to hexamer as calculated by ITC. (E) Titres of VSV-G pseudotyped GFP-encoding HIV-1 vectors 48 h post-infection and levels of reverse transcription (RT) 4 h post-infection under conditions of PF74 inhibition. For both measures, data are normalized to the values obtained in the absence of inhibitor. (F) Data from (E), except plotted against the calculated level of CA occupancy by PF74. The occupancy was calculated assuming that there are 1500 free sites per capsid and that number of free sites = 1500(1−([PF74]/Kd[PF74])) (G) Infectivity and reverse transcription in cells infected in the presence of PF74 (wash) or when removed after four hours (wash out). Reverse transcription was then measured after a further 4 h, while infectivity was determined 48 h post-infection. (H) Levels of reverse transcription 4 h post-infection of HeLa cells in the presence of PF74 and its derivatives at 20× IC9o drug concentrations.](https://figures.cochat.ai/paper-figures/fc100b1cf62b406592ce6fd8f22ac865/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cleavage and polyadenylation specificity factor 6 (CPSF6), which is a component of the cellular pre-mRNA cleavage and polyadenylation machinery79, binds the same region of capsid as Nup153 (REF.78,80).”
From Structure and function of retroviral integrase (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984 · cited 1×
“The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.”
MethodLigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471 · cited 1×
“Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond.”
BackgroundIn Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Specific incorporation of cyclophilin A into HIV-1 virions
Franke, E. K., Yuan, H. E. H., & Luban, J. (1994) · Nature · doi:10.1038/372359a0 · Cited by 745
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 2×
“proteins TNPO3, NUP153, NUP358 [4,5,6], and LEDGF [7].”
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523 · cited 4×
“One potential explanation for this is that all three structures were solved using monomeric CA NTD, whereas a fully assembled HIV-1 capsid is comprised exclusively of multimeric CA, predominately hexamers, containing both NTD-NTD and NTD-CTD interfaces [31].”
BackgroundInfluentialForshey, B. M., von Schwedler, U., Sundquist, W. I., & Aiken, C. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5667-5677.2002 · Cited by 522 · cited 2×
“Viral dependence on post-entry cofactors is dictated by CA whilst CA mutations affect all post-entry processes from reverse transcription to integration site selection [9,10,13,14,15].”
BackgroundSelf-citationSchaller, T., Ocwieja, K. E., Rasaiyaah, J., Price, A. J., Brady, T. L., Roth, S. L., Hué, S., Fletcher, A. J., Lee, K., KewalRamani, V. N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002439 · Cited by 470 · cited 4×
“Viral dependence on post-entry cofactors is dictated by CA whilst CA mutations affect all post-entry processes from reverse transcription to integration site selection [9,10,13,14,15].”
BackgroundInfluentialSelf-citationFlexible Use of Nuclear Import Pathways by HIV-1
Lee, K., Ambrose, Z., Martin, T. D., Oztop, I., Mulky, A., Julias, J. G., Vandegraaff, N., Baumann, J. G., Wang, R., Yuen, W., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.02.007 · Cited by 460 · cited 4×
“Engagement of CPSF6 is not required for HIV-1 infection in transformed cell lines [2] but is tightly correlated with dependence on the nuclear entry cofactors TNPO3, NUP153 and NUP358 [38].”
BackgroundInfluentialHIV-1 evades innate immune recognition through specific cofactor recruitment
Rasaiyaah, J., Tan, C. P., Fletcher, A. J., Price, A. J., Blondeau, C., Hilditch, L., Jacques, D. A., Selwood, D. L., James, L. C., Noursadeghi, M., et al. (2013) · Nature · doi:10.1038/nature12769 · Cited by 458 · cited 8×
“by revealing HIV-1 to innate immune sensing [3].”
BackgroundInfluentialSelf-citationHost Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I., Cagney, G., Diamond, T. L., Zhou, H., Hazuda, D. J., Espeseth, A. S., König, R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000437 · Cited by 452 · cited 7×
“This is reminiscent of CypA and NUP358, which similarly compete for binding [16].”
InfluentialChapter 5 Generation of High-Titer Pseudotyped Retroviral Vectors with Very Broad Host Range
Yee, J.-K., Friedmann, T., & Burns, J. C. (1994) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60600-7 · Cited by 448
Gallivan, J. P., & Dougherty, D. A. (2000) · Journal of the American Chemical Society · doi:10.1021/ja991755c · Cited by 448 · cited 1×
“Cation-p interactions such as those between arginine and tryptophan can contribute significantly to binding energy, and computational studies suggest that in a solvent-accessible environment they are twice as strong as a typical salt bridge [36].”
BackgroundCyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
Towers, G. J., Hatziioannou, T., Cowan, S., Goff, S. P., Luban, J., & Bieniasz, P. D. (2003) · Nature Medicine · doi:10.1038/nm910 · Cited by 377 · cited 1×
“Inhibition of CypA with cyclosporine reduces viral infectivity [8], promotes innate immune sensing [3] and alters the site of viral integration [9].”
BackgroundCapsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells
Yamashita, M., & Emerman, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5670-5678.2004 · Cited by 325 · cited 1×
“Viral dependence on post-entry cofactors is dictated by CA whilst CA mutations affect all post-entry processes from reverse transcription to integration site selection [9,10,13,14,15].”
BackgroundHIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention
Blair, W. S., Pickford, C., Irving, S. L., Brown, D. G., Anderson, M., Bazin, R., Cao, J., Ciaramella, G., Isaacson, J., Jackson, L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001220 · Cited by 291 · cited 4×
“CPSF6, PF74 and BI-2 have all been shown to interact directly with HIV-1 CA NTD by isothermal titration calorimetry (ITC) [21,27,28], whilst NUP153 from cell lysate has been shown to cosediment with His-tagged CA protein [20].”
BackgroundInfluentialAPOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Perez-Caballero, D., Göttlinger, H., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 281 · cited 1×
“5 mg HIV-1 Gag-Pol expression plasmid (pCRV-1 [41]), 1.”
Matreyek, K. A., Yücel, S. S., Li, X., & Engelman, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003693 · Cited by 280 · cited 10×
“For example, CA mutant N74D abolishes binding to CPSF6 [21] but not NUP153 [20].”
BackgroundMethodInfluentialCyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells
Braaten, D., & Luban, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1300 · Cited by 278 · cited 1×
“CypA and NUP358 bind directly to an exposed loop in the CA NTD [16,17] and loop mutations such as G89A or P90A that impair CA:CypA interactions phenocopy CypA deletion [18].”
BackgroundComplementary assays reveal a relationship between HIV-1 uncoating and reverse transcription
Hulme, A. E., Perez, O., & Hope, T. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014522108 · Cited by 276 · cited 1×
“Viral dependence on post-entry cofactors is dictated by CA whilst CA mutations affect all post-entry processes from reverse transcription to integration site selection [9,10,13,14,15].”
BackgroundCPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication
Price, A. J., Fletcher, A. J., Schaller, T., Elliott, T., Lee, K., KewalRamani, V. N., Chin, J. W., Towers, G. J., & James, L. C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002896 · Cited by 264 · cited 22×
“Examination of the ITC data reveals that this is indeed the case and binding of BI-2 occurs with a negative DS whereas it is positive with the other ligands (Figure 1A).”
BackgroundInfluentialSelf-citationTransportin-SR2 Imports HIV into the Nucleus
Christ, F., Thys, W., De Rijck, J., Gijsbers, R., Albanese, A., Arosio, D., Emiliani, S., Rain, J.-C., Benarous, R., Cereseto, A., et al. (2008) · Current Biology · doi:10.1016/j.cub.2008.07.079 · Cited by 245
Shi, J., Zhou, J., Shah, V. B., Aiken, C., & Whitby, K. (2011) · Journal of Virology · doi:10.1128/jvi.01406-10 · Cited by 243 · cited 4×
“PF74 has been reported to destabilize the capsid [29] and our structures suggest a mechanism by which this could occur, namely by inducing changes at the CTD-CTD interface around helices 8 and 9 that hold hexamers together.”
BackgroundInfluentialSelf-citationMatreyek, K. A., & Engelman, A. (2011) · Journal of Virology · doi:10.1128/jvi.00325-11 · Cited by 217 · cited 2×
“NUP153 depletion does not affect reverse transcription but blocks nuclear entry [22].”
BackgroundHIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Ocwieja, K. E., Brady, T. L., Ronen, K., Huegel, A., Roth, S. L., Schaller, T., James, L. C., Towers, G. J., Young, J. A. T., Chanda, S. K., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001313 · Cited by 212 · cited 16×
“We mutated these residues and tested their sensitivity to restriction by CPSF6DNLS and TRIM-NUP153 and their dependence on TNPO3.”
BackgroundInfluentialSelf-citationEvidence for Direct Involvement of the Capsid Protein in HIV Infection of Nondividing Cells
Yamashita, M., Perez, O., Hope, T. J., & Emerman, M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030156 · Cited by 200 · cited 1×
“For instance, mutants T54A/N57A and Q63A/Q67A (which are sensitive to the synthetic restriction factor TRIM-CPSF6 but not TRIM-NUP153 [20]) have reduced infection in nondividing HeLa cells but only T54A/N57A has reduced infectivity in nondividing macrophages [26].”
BackgroundKrishnan, L., Matreyek, K. A., Oztop, I., Lee, K., Tipper, C. H., Li, X., Dar, M. J., KewalRamani, V. N., & Engelman, A. (2010) · Journal of Virology · doi:10.1128/jvi.01899-09 · Cited by 181 · cited 16×
“We mutated these residues and tested their sensitivity to restriction by CPSF6DNLS and TRIM-NUP153 and their dependence on TNPO3.”
BackgroundInfluentialHIV-1 uncoating: connection to nuclear entry and regulation by host proteins
Ambrose, Z., & Aiken, C. (2014) · Virology · doi:10.1016/j.virol.2014.02.004 · Cited by 162 · cited 1×
“CPSF6 may also have a role in nuclear import by recruiting TNPO3 to the virus and providing transport to active nuclear pores [23].”
BackgroundSelf-citationStructural basis for nuclear import of splicing factors by human Transportin 3
Maertens, G. N., Cook, N. J., Wang, W., Hare, S., Gupta, S. S., Öztop, I., Lee, K., Pye, V. E., Cosnefroy, O., Snijders, A. P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320755111 · Cited by 162 · cited 1×
“Further evidence for a link between CPSF6 and TNPO3 include data showing that mutants of TNPO3 that are selectively impaired for interaction with CPSF6 do not support HIV-1 infection [24], whilst TNPO3-depleted cells are refractory to wild-type HIV-1 infection only in the presence of endogenous CPSF6 [25].”
BackgroundTNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm
De Iaco, A., Santoni, F., Vannier, A., Guipponi, M., Antonarakis, S., & Luban, J. (2013) · Retrovirology · doi:10.1186/1742-4690-10-20 · Cited by 140 · cited 2×
“Further evidence for a link between CPSF6 and TNPO3 include data showing that mutants of TNPO3 that are selectively impaired for interaction with CPSF6 do not support HIV-1 infection [24], whilst TNPO3-depleted cells are refractory to wild-type HIV-1 infection only in the presence of endogenous CPSF6 [25].”
BackgroundDisulfide Bond Stabilization of the Hexameric Capsomer of Human Immunodeficiency Virus
Pornillos, O., Ganser-Pornillos, B. K., Banumathi, S., Hua, Y., & Yeager, M. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.06.042 · Cited by 132 · cited 2×
“HIV-1 CA hexameric proteins, stabilized by engineered intersubunit disulfide bonds, were produced by assembly of recombinant CA containing four amino acid substitutions, as previously reported [33].”
BackgroundMethodThe Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating
Shah, V. B., Shi, J., Hout, D. R., Oztop, I., Krishnan, L., Ahn, J., Shotwell, M. S., Engelman, A., & Aiken, C. (2013) · Journal of Virology · doi:10.1128/jvi.07177-11 · Cited by 126 · cited 2×
“Depletion of TNPO3 or NUP153 reduces PF74 inhibition at low but not high doses, as do CA mutants such as N74D or the expression of TRIM-NUP153 [20,37].”
BackgroundSelf-citationDiscovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid Complexes
Lamorte, L., Titolo, S., Lemke, C. T., Goudreau, N., Mercier, J.-F., Wardrop, E., Shah, V. B., von Schwedler, U. K., Langelier, C., Banik, S. S. R., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00985-13 · Cited by 119
Self-citationHIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358
Bichel, K., Price, A. J., Schaller, T., Towers, G. J., Freund, S. M., & James, L. C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-81 · Cited by 114 · cited 2×
“This is reminiscent of CypA and NUP358, which similarly compete for binding [16].”
BackgroundSelf-citationDe Iaco, A., & Luban, J. (2011) · Retrovirology · doi:10.1186/1742-4690-8-98 · Cited by 92 · cited 4×
“Previously, we have shown that CPSF6 interface mutants N57A, Q67A, K70A, N74D and T107A are all resistant to restriction by CPSF6DNLS [21].”
BackgroundInfluentialByeon, I.-J. L., Hou, G., Han, Y., Suiter, C. L., Ahn, J., Jung, J., Byeon, C.-H., Gronenborn, A. M., & Polenova, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300937v · Cited by 89 · cited 2×
“This interpretation is supported by NMR experiments, which show that loop177–182 isomerizes between two discrete conformers [34].”
BackgroundResultHIV-1 Capsid-Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6
Lee, K., Mulky, A., Yuen, W., Martin, T. D., Meyerson, N. R., Choi, L., Yu, H., Sawyer, S. L., & KewalRamani, V. N. (2012) · Journal of Virology · doi:10.1128/jvi.06607-11 · Cited by 81 · cited 1×
“The dramatic effect of G318 mutation on CPSF6 binding correlates with the reduced ability of NLS deleted CPSF6 mutant G318A to restrict HIV-1 [35].”
BackgroundZhao, Y., Chen, Y. Q., Schutkowski, M., Fischer, G., & Ke, H. (1997) · Structure · doi:10.1016/s0969-2126(97)00172-x · Cited by 80 · cited 1×
“CypA and NUP358 bind directly to an exposed loop in the CA NTD [16,17] and loop mutations such as G89A or P90A that impair CA:CypA interactions phenocopy CypA deletion [18].”
BackgroundHuman Cytosolic Extracts Stabilize the HIV-1 Core
Fricke, T., Brandariz-Nuñez, A., Wang, X., Smith, A. B., & Diaz-Griffero, F. (2013) · Journal of Virology · doi:10.1128/jvi.01705-13 · Cited by 56 · cited 1×
“Understanding the effect of ligand binding on intact capsid is of particular interest as there are conflicting reports on the effect of PF74 and BI-2 on capsid stability [28,29,32].”
BackgroundHori, T., Takeuchi, H., Saito, H., Sakuma, R., Inagaki, Y., & Yamaoka, S. (2013) · Journal of Virology · doi:10.1128/jvi.00124-13 · Cited by 48 · cited 2×
“Expression of CPSF6 lacking its nuclear localisation sequence (CPSF6DNLS) blocks reverse transcription [3,30], as does PF74, while BI-2 inhibits infection post-reverse transcription [28,29,30].”
BackgroundHenning, M. S., Dubose, B. N., Burse, M. J., Aiken, C., & Yamashita, M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003868 · Cited by 47
Self-citation
Cited by
HIV-1 assembly, release and maturation
Freed, E. O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3490 · Cited by 654
Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.001 · Cited by 552
Self-citationThe Structure of the Nuclear Pore Complex (An Update)
Lin, D. H., & Hoelz, A. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011901 · Cited by 478
Clinical targeting of HIV capsid protein with a long-acting small molecule
Link, J. O., Rhee, M. S., Tse, W. C., Zheng, J., Somoza, J. R., Rowe, W., Begley, R., Chiu, A., Mulato, A., Hansen, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2443-1 · Cited by 425
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
Metadata
- Authors
- Price, A. J., Jacques, D. A., McEwan, W. A., Fletcher, A. J., Essig, S., Chin, J. W., Halambage, U. D., Aiken, C., & James, L. C.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Vanderbilt University (US)
- Corresponding author
- James, Leo C.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-30
- Volume
- 10
- Issue
- 10
- Pages
- e1004459
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4214760
- OpenAlex
- W2170915201
- Cited by
- 284
- References
- 45
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 23 · 2023: 24 · 2022: 21 · 2021: 41 · 2020: 31 · 2019: 28 · 2018: 24 · 2017: 8 · 2016: 19 · 2015: 20 · 2014: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Funders
- National Institutes of Health
- Medical Research Council (U105181010)
- National Health and Medical Research Council (1036521)
- National Institute of Allergy and Infectious Diseases (R01AI089401)
- FP7 Ideas: European Research Council (281627)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 capsid, host cofactors, Nup153, CPSF6, capsid disassembly, conformational dynamics, antiretroviral drugs
- MeSH terms
- Binding Sites, Capsid, Humans, Indoles, Ligands, Models, Molecular, Models, Structural, Mutation, Phenylalanine, Polycyclic Compounds, Protein Binding, Virion, HIV-1, HIV Infections, Protein Structure, Tertiary, Anti-HIV Agents, Nuclear Pore Complex Proteins, Capsid Proteins, mRNA Cleavage and Polyadenylation Factors, Reverse Transcription, Polymerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.